MDM2-ARF complex regulates p53 sumoylation

被引:106
作者
Chen, LH [1 ]
Chen, JD [1 ]
机构
[1] H Lee Moffit Comprehens Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA
基金
美国国家卫生研究院;
关键词
p53; mdm2; ARF; sumoylation;
D O I
10.1038/sj.onc.1206851
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor is regulated by MDM2-mediated ubiquitination and degradation. Ubiquitination of p53 is regulated by ARF, which binds to MDM2 and inhibits its E3 ligase function. P53 is also subjected to modification by conjugation of SUMO-1. We found that a p53 mutant deficient for MDM2 binding (p53(14Q19S)) is poorly sumoylated in vivo compared to wild-type p53. Overexpression of MDM2 increases the level of p53 sumoylation, which is further stimulated by expression of ARE Stimulation of p53 sumoylation requires a highly conserved region (102-116) encoded by exon 2 of ARF and correlates with the ability of ARF to target p53 to the nucleolus. An MDM2 deletion mutant (MDM2(Delta222-437)) with activated cryptic nucleolar localization signal also targets p53 to the nucleolus and efficiently promotes p53 sumoylation in the absence of ARE Direct targeting of p53 to the nucleolus enhances its sumoylation in an MDM2- and ARF-dependent fashion. These results show that p53 sumoylation is regulated by MDM2- and ARF-mediated nucleolar targeting.
引用
收藏
页码:5348 / 5357
页数:10
相关论文
共 31 条
[1]   REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE [J].
CHEN, JD ;
LIN, JY ;
LEVINE, AJ .
MOLECULAR MEDICINE, 1995, 1 (02) :142-152
[2]   MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS [J].
CHEN, JD ;
MARECHAL, V ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4107-4114
[3]   Differential regulation of sentrinized proteins by a novel sentrin-specific protease [J].
Gong, LM ;
Millas, S ;
Maul, GG ;
Yeh, ETH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (05) :3355-3359
[4]   Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 [J].
Gostissa, M ;
Hengstermann, A ;
Fogal, V ;
Sandy, P ;
Schwarz, SE ;
Scheffner, M ;
Del Sal, G .
EMBO JOURNAL, 1999, 18 (22) :6462-6471
[5]   SP-RING for SUMO: New functions bloom for a ubiquitin-like protein [J].
Hochstrasser, M .
CELL, 2001, 107 (01) :5-8
[6]   p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2 [J].
Ito, A ;
Lai, CH ;
Zhao, X ;
Saito, S ;
Hamilton, MH ;
Appella, E ;
Yao, TP .
EMBO JOURNAL, 2001, 20 (06) :1331-1340
[7]   MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation [J].
Ito, A ;
Kawaguchi, Y ;
Lai, CH ;
Kovacs, JJ ;
Higashimoto, Y ;
Appella, E ;
Yao, TP .
EMBO JOURNAL, 2002, 21 (22) :6236-6245
[8]   Involvement of PIAS1 in the sumoylation of tumor suppressor p53 [J].
Kahyo, T ;
Nishida, T ;
Yasuda, H .
MOLECULAR CELL, 2001, 8 (03) :713-718
[9]   MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins [J].
Kobet, E ;
Zeng, XY ;
Zhu, Y ;
Keller, D ;
Lu, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12547-12552
[10]   Functional analysis and intracellular localization of p53 modified by SUMO-1 [J].
Kwek, SSS ;
Derry, J ;
Tyner, AL ;
Shen, ZY ;
Gudkov, AV .
ONCOGENE, 2001, 20 (20) :2587-2599